z-logo
open-access-imgOpen Access
PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration
Author(s) -
Kévin Duarte,
Solveig Heide,
Sandrine PoëaGuyon,
Véronique Rousseau,
Christel Depienne,
Agnès Rastetter,
Caroline Nava,
Tania AttiéBitach,
Ferechté Razavi,
Jéléna Martinovic,
Marie Laure Moutard,
Jacqueline Cherfils,
Cyril Mignot,
Delphine Héron,
JeanVianney Barnier
Publication year - 2019
Publication title -
neurobiology of disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.205
H-Index - 166
eISSN - 1095-953X
pISSN - 0969-9961
DOI - 10.1016/j.nbd.2019.104709
Subject(s) - microcephaly , missense mutation , corpus callosum agenesis , intellectual disability , mutation , biology , epilepsy , neuroscience , corpus callosum , genetics , gene
Corpus callosum agenesis (CCA) is a brain malformation associated with a wide clinical spectrum including intellectual disability (ID) and an etiopathological complexity. We identified a novel missense G424R mutation in the X-linked p21-activated kinase 3 (PAK3) gene in a boy presenting with severe ID, microcephaly and CCA and his fetal sibling with CCA and severe hydrocephaly. PAK3 kinase is known to control synaptic plasticity and dendritic spine dynamics but its implication is less characterized in brain ontogenesis. In order to identify developmental functions of PAK3 impacted by mutations responsible for CCA, we compared the biochemical and biological effects of three PAK3 mutations localized in the catalytic domain. These mutations include two "severe" G424R and K389N variants (responsible for severe ID and CCA) and the "mild" A365E variant (responsible for nonsyndromic mild ID). Whereas they suppressed kinase activity, only the two severe variants displayed normal protein stability. Furthermore, they increased interactions between PAK3 and the guanine exchange factor αPIX/ARHGEF6, disturbed adhesion point dynamics and cell spreading, and severely impacted cell migration. Our findings highlight new molecular defects associated with mutations responsible for severe clinical phenotypes with developmental brain defects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom